US EditionTerbium therapy shows promise in fighting lymphoma
6 Articles
6 Articles
Terbium therapy shows promise in fighting lymphoma
Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by promising results from experiments carried out at the Paul Scherrer Institute PSI in collaboration with Inselspital - Bern University Hospital.
Elisa Rioja-Blanco and Martin Béhé are working together at the Center for Radiopharmaceutical Sciences in the Center for Life Sciences at PSI. © Paul Scherrer Institut PSI/Mahir Dzambegovic DMZ – MEDIZIN ¦ Anton Aeberhard ¦ Villigen – Advanced therapy with the radioactive element Terbium-161 could revolutionize the treatment of lymph gland cancer. Researchers from the Paul Scherrer Institute (PSI) and the Inselspital Bern report on promising res…
Scientists unveil terbium-161 breakthrough in targeted lymphoma treatment
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 This innovative breakthrough, detailed in the Journal of Nuclear Medicine, involves attaching terbium-161 to an antibody that targets the CD30 receptor, which is present in many lymphoma cells. Researchers at PSI’s Center for Radiopharm…
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
